Supplier of prescription, OTC, and nutraceutical drugs, ScripsAmerica announced earlier today the addition of a new section to the company's website, scripsamerica.com, that will serve as an in-depth source of shareholder information. Management will continuously update the new web section.
The brand new section is titled as "Q & A" and provides updated content in the format of answers to commonly asked investor questions regarding ScripsAmerica. The general scope of information provided will state general information about the company, its revenue generating business models, strategic shifts in these areas over the past year, financial information including share structure and capitalization, as well as the market potential in its target markets, and the growth expectations heading into 2014 and the coming years.
CEO of ScripsAmerica, Bob Schneiderman, stated, "Scrips' management is strongly committed to not only maximizing shareholder value at all times, but also keeping our current and potential investors informed about the company's mission, growth strategy and upcoming milestones. The new 'Q & A' section of our website will serve as a comprehensive resource that provides updates on the company's business developments in a more concise and conversational manner than our filings. We feel that this is an ideal time to create a new avenue of shareholder communication as ScripsAmerica is entering a period where we anticipate significant revenue growth beginning in the first quarter of 2014."
To learn more please visit ScripsAmerica.com
QualityStocks provides investor relations services to publicly traded companies in exchange for compensation. This article may be part of our efforts to widen a client's exposure. To read our full disclaimer, visit http://disclaimer.qualitystocks.net